Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-02
DOI
10.1002/pbc.29460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
- (2021) Monika Sparber-Sauer et al. BRITISH JOURNAL OF CANCER
- Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)
- (2020) Michela Casanova et al. EUROPEAN JOURNAL OF CANCER
- Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors
- (2020) Elena V. Preobrazhenskaya et al. PEDIATRIC BLOOD & CANCER
- The 2020 WHO Classification
- (2020) Michael E. Kallen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies
- (2020) Daniel Orbach et al. EUROPEAN JOURNAL OF CANCER
- Inflammatory myofibroblastic tumors-A retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe
- (2018) Stefanie Kube et al. PEDIATRIC BLOOD & CANCER
- Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study
- (2017) Yael P. Mossé et al. JOURNAL OF CLINICAL ONCOLOGY
- The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors
- (2017) Luca Felkai et al. PATHOLOGY & ONCOLOGY RESEARCH
- ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors
- (2016) Ali H. Alassiri et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Complete and Repeated Response of a Metastatic ALK-rearranged Inflammatory Myofibroblastic Tumor to Crizotinib in a Teenage Girl
- (2016) Jérémie Gaudichon et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors
- (2015) Jason L Hornick et al. MODERN PATHOLOGY
- Neoadjuvant Crizotinib in Advanced Inflammatory Myofibroblastic Tumour with ALK Gene Rearrangement
- (2015) Shereen Rafee et al. TUMORI
- Neoadjuvant Crizotinib in Advanced Inflammatory Myofibroblastic Tumour with ALK Gene Rearrangement
- (2015) Shereen Rafee et al. TUMORI JOURNAL
- Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
- (2014) C. M. Lovly et al. Cancer Discovery
- Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review
- (2013) Jian Li et al. Diagnostic Pathology
- Inflammatory Myofibroblastic Tumors in Childhood
- (2013) Bhakti Mehta et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory myofibroblastic tumor of the conjunctiva: Response to chemotherapy with low-dose methotrexate and vinorelbine
- (2009) Francesca Favini et al. PEDIATRIC BLOOD & CANCER
- Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts
- (2008) Xiaofei Qiu et al. HUMAN PATHOLOGY
- Inflammatory myofibroblastic tumours: where are we now?
- (2007) B C Gleason et al. JOURNAL OF CLINICAL PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now